Cargando…

Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014

Antiviral treatment of immunocompromised patients with prolonged influenza virus infection can lead to multidrug resistance. This study reveals the selection of antiviral resistance mutations in influenza A(H1N1)pdm09 virus in an immunocompromised patient during a 6-month period. The patient was tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trebbien, Ramona, Pedersen, Svend Stenvang, Vorborg, Kristine, Franck, Kristina Træholt, Fischer, Thea Kølsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322288/ https://www.ncbi.nlm.nih.gov/pubmed/28128091 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.3.30445

Ejemplares similares

I223R Mutation in Influenza A(H1N1)pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y
por: LeGoff, Jérome, et al.
Publicado: (2012)

Reassortant Influenza A(H1N1)pdm09 Virus in Elderly Woman, Denmark, January 2021
por: Nissen, Jakob N., et al.
Publicado: (2021)

Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013–2014 influenza season in Mainland China
por: Huang, Weijuan, et al.
Publicado: (2015)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir
por: Da Dalt, Liviana, et al.
Publicado: (2010)

Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment
por: Tuna, Nazan, et al.
Publicado: (2012)

Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2015)

Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series
por: Torti, Carlo, et al.
Publicado: (2019)

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
por: Matsuzaki, Yoko, et al.
Publicado: (2010)

Prevalence of Influenza A(H1N1)pdm09 Virus Resistant to Oseltamivir in Shiraz, Iran, During 2012 - 2013
por: Khodadad, Nastaran, et al.
Publicado: (2015)

Severe myocarditis due to influenza A(H1N1)pdm09 viral infection in a young woman successfully treated with intravenous zanamivir: A case report
por: Mazzitelli, Maria, et al.
Publicado: (2019)

Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)?
por: Yu, Kunqian, et al.
Publicado: (2009)

Oseltamivir/zanamivir: Lack of efficacy leading to fatal influenza A (H1N1) infection: case report
Publicado: (2013)

Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia
por: Hurt, A. C., et al.
Publicado: (2012)

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses
por: Butler, Jeff, et al.
Publicado: (2014)

Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020
por: Mohan, Teena, et al.
Publicado: (2021)

A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir
por: Abed, Yacine, et al.
Publicado: (2017)

Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017
por: Kyaw Win, Su Mon, et al.
Publicado: (2020)

Delayed emergence of oseltamivir‐resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar
por: Dapat, Clyde, et al.
Publicado: (2012)

Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir
por: Meijer, Wouter J., et al.
Publicado: (2015)

IF-03 Clinical Effectiveness of Oseltamivir or Zanamivir for Influenza A/H1N1 Virus with or without H274Y Mutation
por: Kawai, Naoki, et al.
Publicado: (2009)

Study of Oseltamivir and Zanamivir Resistance-Related Mutations in Influenza Viruses Isolated from Wild Mallards in Sweden
por: Orozovic, Goran, et al.
Publicado: (2014)

745. Surveillance for Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus Infections During 2016–2017 and 2017–2018, United States
por: Spencer, Sarah, et al.
Publicado: (2018)

Community- and hospital-acquired infections with oseltamivir- and peramivir-resistant influenza A(H1N1)pdm09 viruses during the 2015–2016 season in Japan
por: Hibino, Akinobu, et al.
Publicado: (2016)

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
por: Juvet, Lene Kristine, et al.
Publicado: (2021)

Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds
por: Orozovic, Goran, et al.
Publicado: (2011)

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial
por: Li, Min, et al.
Publicado: (2020)

Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons
por: Monamele, Chavely Gwladys, et al.
Publicado: (2019)

Differential Viral-Host Immune Interactions Associated with Oseltamivir-Resistant H275Y and Wild-Type H1N1 A(pdm09) Influenza Virus Pathogenicity
por: Vidaña, Beatriz, et al.
Publicado: (2020)

Influenza A(H1N1)pdm09 virus and asthma
por: Obuchi, Masatsugu, et al.
Publicado: (2013)

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
por: Liu, Mi, et al.
Publicado: (2023)

Molecular features of influenza A (H1N1)pdm09 prevalent in Mexico during winter seasons 2012-2014
por: Arellano-Llamas, Rocío, et al.
Publicado: (2017)

Compliance to Oseltamivir among Two Populations in Oxfordshire, United Kingdom Affected by Influenza A(H1N1)pdm09, November 2009 – A Waste Water Epidemiology Study
por: Singer, Andrew C., et al.
Publicado: (2013)

Estimated Number of Patients with Influenza A(H1)pdm09, or Other Viral Types, from 2010 to 2014 in Japan
por: Murakami, Yoshitaka, et al.
Publicado: (2016)

Incidence and Cost of Rotavirus Hospitalizations in Denmark
por: Fischer, Thea Kølsen, et al.
Publicado: (2007)

Neurological events related to influenza A (H1N1) pdm09
por: Cárdenas, Graciela, et al.
Publicado: (2014)

The 2015 influenza A (H1N1) pdm09 outbreak in India
por: Murhekar, Manoj, et al.
Publicado: (2016)

Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
por: Ambrozaitis, Arvydas, et al.
Publicado: (2016)

A(H1N1)pdm09 influenza infection: vaccine inefficiency
por: Friedman, Nehemya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b1gc96jrm6mtmdt46u89h1vp34